Virax Biolabs Group Aktie

Kaufen

Verkaufen

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Bei einem anderen Broker handeln Smartphone

WKNA3DN3P

ISINKYG9495L1095

SymbolVRAX

Virax Biolabs Group Aktien News

Sortieren:Datum Meistgelesen

18.03.25PR NewswireVirax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

13.03.25PR NewswireVirax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

05.03.25PR NewswireVirax Biolabs to Present at 19th World Immune Regulation Meeting

25.02.25PR NewswireVirax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

17.12.24PR NewswireVirax Biolabs' CEO James Foster Issues Letter to Shareholders

10.12.24PR NewswireVirax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

23.10.24PR NewswireVirax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

16.09.24PR NewswireVirax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

09.09.24PR NewswireVirax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

29.08.24PR NewswireVirax Biolabs to Participate at 7th European Congress of Immunology

28.08.24PR NewswireVirax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

25.04.24PR NewswireVirax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

16.04.24PR NewswireVirax Biolabs to Participate at ESCMID Global 2024

15.03.24PR NewswireVirax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

21.12.23PR NewswireVirax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

18.12.23PR NewswireVirax Biolabs' CEO James Foster Issues Letter to Shareholders

14.12.23PR NewswireVirax Biolabs Group Limited Announces 1-for-10 Share Consolidation

12.09.23PR NewswireVirax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

01.09.23PR NewswireVirax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

03.08.23PR NewswireNasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

18.07.23PR NewswireVirax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

14.06.23PR NewswireVirax Biolabs' CEO James Foster Issues Letter to Shareholders

04.05.23PR NewswireVirax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

19.04.23PR NewswireVirax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

10.03.23PR NewswireVirax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

07.03.23PR NewswireVirax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

07.02.23PR NewswireVirax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

06.02.23PR NewswireVirax Biolabs to Present at the 2023 BIO CEO & Investor Conference

02.02.23PR NewswireVirax Biolabs' CEO James Foster Issues Letter to Shareholders

04.01.23PR NewswireVirax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

06.12.22PR NewswireCOVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

15.11.22PR NewswireVirax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

08.11.22PR NewswireVirax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

04.11.22PR NewswireVirax Biolabs Group Limited Announces $3.8 Million Private Placement

03.11.22PR NewswireVirax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

26.10.22PR NewswireVirax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

22.09.22PR NewswireVirax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

12.09.22PR NewswireVirax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

06.09.22PR NewswireVirax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

Virax Biolabs Group News

Virax Biolabs Group News: auf dieser Seite finden Sie alle Virax Biolabs Group News und Nachrichten zur Virax Biolabs Group Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Virax Biolabs Group News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Virax Biolabs Group News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.